Bi Chen Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

4/2023	Real world experience with camrelizumab in patients with advanced non-small cell lung cancer: a prospective multicenter cohort study (NOAH-LC-101).
1/2023	SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer.
1/2022	The Pharmacological Mechanism of Curcumin against Drug Resistance in Non-Small Cell Lung Cancer: Findings of Network Pharmacology and Bioinformatics Analysis.
10/2021	Surgical perspective in neoadjuvant chemoimmunotherapy for stage II-III non-small cell lung cancer.
1/2021	β-elemene enhances the antitumor activity of erlotinib by inducing apoptosis through AMPK and MAPK pathways in TKI-resistant H1975 lung cancer cells.
1/2018	Downregulation of BarH-like homeobox 2 promotes cell proliferation, migration and aerobic glycolysis through Wnt/β-catenin signaling, and predicts a poor prognosis in non-small cell lung carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bi Chen Research Topics

Disease

24	Neoplasms (Cancer) 01/2024 - 10/2003
12	Wounds and Injuries (Trauma) 01/2019 - 06/2002
8	Burns 04/2012 - 10/2003
7	Chronic Obstructive Pulmonary Disease (COPD) 08/2023 - 12/2013
7	Lung Neoplasms (Lung Cancer) 09/2022 - 01/2020
7	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2020 - 05/2008
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2023 - 01/2018
5	Fibrosis (Cirrhosis) 11/2021 - 07/2014
5	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2019
5	Inflammation (Inflammations) 12/2019 - 06/2009
4	Adenocarcinoma of Lung 01/2022 - 07/2019
3	Asthma (Bronchial Asthma) 02/2024 - 08/2017
3	Ischemic Stroke 03/2023 - 07/2007
3	Neoplasm Metastasis (Metastasis) 09/2022 - 10/2016
3	Brain Ischemia (Cerebral Ischemia) 06/2009 - 07/2007
3	Cicatrix (Scar) 12/2007 - 05/2002
2	Stomach Neoplasms (Stomach Cancer) 01/2024 - 03/2020
2	Dyspnea (Shortness of Breath) 01/2023 - 01/2022
2	Hepatocellular Carcinoma (Hepatoma) 10/2021 - 01/2020
2	Obstructive Sleep Apnea 03/2021 - 09/2015
2	Lung Diseases (Lung Disease) 03/2021 - 06/2020
2	Intervertebral Disc Displacement (Herniated Disc) 01/2021 - 02/2016
2	Hemorrhage 01/2020 - 02/2006
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 01/2015
2	Idiopathic Pulmonary Fibrosis 12/2018 - 01/2016
2	Edema (Dropsy) 05/2013 - 12/2005
2	Ischemia 06/2009 - 05/2007
2	Hypertrophic Cicatrix (Hypertrophic Scar) 12/2007 - 07/2002
2	Necrosis 05/2007 - 10/2006
1	Pathologic Processes 01/2024
1	Spontaneous Abortion (Miscarriage) 01/2024
1	Thrombosis (Thrombus) 03/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2023
1	Colonic Neoplasms (Colon Cancer) 01/2023
1	Hypertension (High Blood Pressure) 01/2022
1	Coronary Disease (Coronary Heart Disease) 01/2022
1	Sleepiness 01/2022
1	Hypertrophy 01/2022
1	Obesity 01/2022
1	Hyperplasia 01/2022

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2016
7	Therapeutic UsesIBA 01/2024 - 05/2002
5	Bile Acids and Salts (Bile Acids)IBA 07/2020 - 01/2016
4	RNA (Ribonucleic Acid)IBA 01/2024 - 12/2007
4	elemeneIBA 01/2021 - 01/2020
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2015
4	Insulin (Novolin)FDA Link 04/2012 - 06/2007
4	salicylhydroxamic acid (SHAM)IBA 06/2009 - 06/2007
3	Hormones (Hormone)IBA 01/2024 - 06/2009
3	EnzymesIBA 01/2022 - 01/2020
3	CurcuminIBA 01/2022 - 05/2008
3	Messenger RNA (mRNA)IBA 01/2020 - 12/2007
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2023 - 01/2022
2	baicalinIBA 12/2021 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 07/2019
2	Cisplatin (Platino)FDA LinkGeneric 02/2020 - 01/2020
2	Estrogens (Estrogen)FDA Link 01/2020 - 04/2016
2	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 01/2019
2	OvalbuminIBA 12/2019 - 08/2017
2	Dexamethasone (Maxidex)FDA LinkGeneric 12/2019 - 08/2017
2	hydroxide ionIBA 12/2019 - 08/2017
2	Bosentan (Tracleer)FDA Link 12/2019 - 08/2017
2	Estradiol (Delestrogen)FDA LinkGeneric 08/2018 - 04/2016
2	SmokeIBA 08/2017 - 11/2016
2	Interleukin-4 (Interleukin 4)IBA 11/2016 - 12/2003
2	Proteins (Proteins, Gene)FDA Link 07/2014 - 05/2008
2	Evans Blue (Blue, Evans)FDA Link 05/2013 - 12/2005
2	p38 Mitogen-Activated Protein KinasesIBA 04/2012 - 08/2008
2	SB 203580IBA 04/2012 - 08/2008
2	CytokinesIBA 04/2012 - 12/2003
2	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 04/2012 - 08/2008
2	Glucose (Dextrose)FDA LinkGeneric 12/2008 - 06/2007
2	Pravastatin (Pravachol)FDA LinkGeneric 09/2007 - 07/2007
2	CollagenIBA 08/2007 - 05/2002
2	erucylphosphocholineIBA 05/2007 - 10/2006
2	PlasticsIBA 04/2007 - 06/2002
2	Peptides (Polypeptides)IBA 12/2005 - 06/2002
2	Substance PIBA 10/2003 - 07/2002
1	6-methyladenineIBA 01/2024
1	N-methyladenosineIBA 01/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	camrelizumabIBA 04/2023
1	TeaIBA 03/2023
1	GoldIBA 01/2023
1	curcumenolIBA 07/2022
1	Long Noncoding RNAIBA 07/2022
1	prednylidene (Pred)IBA 01/2022
1	LipidsIBA 01/2022

Therapy/Procedure

12	Therapeutics 01/2024 - 02/2009
4	Drug Therapy (Chemotherapy) 04/2023 - 01/2020
3	Immunotherapy 01/2024 - 10/2021
3	Skin Transplantation (Skin Grafting) 06/2010 - 02/2006
2	Transplantation 02/2021 - 12/2014
2	Diskectomy (Discectomy) 01/2021 - 02/2016
2	Aftercare (After-Treatment) 12/2019 - 08/2008
1	Acupuncture Points (Acupuncture Point) 02/2024
1	Moxibustion 02/2024
1	Acupuncture Therapy 02/2024
1	Critical Care (Surgical Intensive Care) 08/2023
1	Art Therapy 01/2022